Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-2-23
pubmed:abstractText
The Stanford group has reported excellent results with the Stanford V regimen for patients with bulky and/or advanced Hodgkin lymphoma (HL). However, Gobbi reported markedly inferior failure-free survival (FFS) comparing Stanford V to other regimens but included major deviations from the original program. We retrospectively examined whether treatment at our institution carefully following Stanford V guidelines would confirm the original Stanford outcome data.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1569-8041
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
574-81
pubmed:meshHeading
pubmed-meshheading:19759185-Adolescent, pubmed-meshheading:19759185-Adult, pubmed-meshheading:19759185-Aged, pubmed-meshheading:19759185-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:19759185-Combined Modality Therapy, pubmed-meshheading:19759185-Disease-Free Survival, pubmed-meshheading:19759185-Female, pubmed-meshheading:19759185-Hodgkin Disease, pubmed-meshheading:19759185-Humans, pubmed-meshheading:19759185-Male, pubmed-meshheading:19759185-Middle Aged, pubmed-meshheading:19759185-Neoplasm Recurrence, Local, pubmed-meshheading:19759185-Neoplasm Staging, pubmed-meshheading:19759185-Retrospective Studies, pubmed-meshheading:19759185-Salvage Therapy, pubmed-meshheading:19759185-Survival Rate, pubmed-meshheading:19759185-Treatment Outcome, pubmed-meshheading:19759185-Young Adult
pubmed:year
2010
pubmed:articleTitle
Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience.
pubmed:affiliation
Lymphoma Disease Management Team and Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't